APOTHEEK VITAM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTHEEK VITAM
Largest movements
- Tangible fixed assets -€43,207
down €43,207 (-9.2%), from €469,869 to €426,662
of which Land and buildings: -€42,245
- Receivables within one year -€26,237
down €26,237 (-31.8%), from €82,470 to €56,233
of which Trade receivables: -€29,131
- Cash +€12,701
up €12,701 (+17.6%), from €72,049 to €84,750
mainly Net result for the year (+€77,990) and Depreciation (+€48,997)
- Debts after one year -€84,779
down €84,779 (-42.4%), from €199,784 to €115,005
- Reserves +€44,023
up €44,023 (+11.8%), from €373,370 to €417,393
of which Distributable reserves: +€44,023
- Tax, wage and social debts -€13,953
down €13,953 (-45.6%), from €30,577 to €16,624
of which Taxes: -€13,961
- Other debts +€11,925
up €11,925 (+34.2%), from €34,896 to €46,821
- Trade debts -€11,834
down €11,834 (-20.3%), from €58,373 to €46,539
- Gross operating margin -€24,074
down €24,074 (-9.2%), from €262,751 to €238,677
- Taxes -€15,682
down €15,682 (-42.7%), from €36,726 to €21,044
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €758,624 | €705,881 | -€52,743 | -7.0% |
| Fixed assets | 21/28 | €469,869 | €426,662 | -€43,207 | -9.2% |
| Tangible fixed assets | 22/27 | €469,869 | €426,662 | -€43,207 | -9.2% |
| Land and buildings | 22 | €467,267 | €425,022 | -€42,245 | -9.0% |
| Plant, machinery and equipment | 23 | €2,602 | €1,640 | -€962 | -37.0% |
| Current assets | 29/58 | €288,755 | €279,219 | -€9,536 | -3.3% |
| Stocks and contracts in progress | 3 | €134,236 | €134,427 | +€191 | +0.1% |
| Stocks | 30/36 | €134,236 | €134,427 | +€191 | +0.1% |
| Amounts receivable within one year | 40/41 | €82,470 | €56,233 | -€26,237 | -31.8% |
| Trade receivables | 40 | €82,470 | €53,338 | -€29,131 | -35.3% |
| Other amounts receivable | 41 | - | €2,895 | +€2,895 | |
| Current investments | 50/53 | - | €3,809 | +€3,809 | |
| Cash at bank and in hand | 54/58 | €72,049 | €84,750 | +€12,701 | +17.6% |
| Total equity and liabilities | 10/49 | €758,624 | €705,881 | -€52,743 | -7.0% |
| Equity | 10/15 | €391,970 | €435,993 | +€44,023 | +11.2% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €373,370 | €417,393 | +€44,023 | +11.8% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Tax-exempt reserves | 132 | €143 | €143 | = | 0.0% |
| Distributable reserves | 133 | €371,367 | €415,390 | +€44,023 | +11.9% |
| Amounts payable | 17/49 | €366,654 | €269,888 | -€96,766 | -26.4% |
| Amounts payable after more than one year | 17 | €199,784 | €115,005 | -€84,779 | -42.4% |
| Financial debts | 170/4 | €199,784 | €115,005 | -€84,779 | -42.4% |
| Amounts payable within one year | 42/48 | €163,450 | €151,463 | -€11,987 | -7.3% |
| Current portion of amounts payable after more than one year | 42 | €39,604 | €41,479 | +€1,875 | +4.7% |
| Trade debts | 44 | €58,373 | €46,539 | -€11,834 | -20.3% |
| Suppliers | 440/4 | €58,373 | €46,539 | -€11,834 | -20.3% |
| Taxes, remuneration and social security | 45 | €30,577 | €16,624 | -€13,953 | -45.6% |
| Taxes | 450/3 | €19,055 | €5,094 | -€13,961 | -73.3% |
| Remuneration and social security | 454/9 | €11,522 | €11,530 | +€8 | +0.1% |
| Other amounts payable | 47/48 | €34,896 | €46,821 | +€11,925 | +34.2% |
| Accrued charges and deferred income | 492/3 | €3,420 | €3,420 | = | 0.0% |
| Remuneration, social security and pensions | 62 | €62,737 | €64,102 | +€1,365 | +2.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €48,043 | €48,997 | +€954 | +2.0% |
| Other operating charges | 640/8 | €5,870 | €6,383 | +€513 | +8.7% |
| Gross operating margin | 9900 | €262,751 | €238,677 | -€24,074 | -9.2% |
| Operating profit (loss) | 9901 | €146,101 | €119,195 | -€26,905 | -18.4% |
| Financial income | 75/76B | €3,735 | €1,506 | -€2,229 | -59.7% |
| Recurring financial income | 75 | €3,735 | €1,506 | -€2,229 | -59.7% |
| Financial charges | 65/66B | €23,333 | €21,667 | -€1,666 | -7.1% |
| Recurring financial charges | 65 | €23,333 | €21,667 | -€1,666 | -7.1% |
| Profit (loss) for the period before taxes | 9903 | €126,503 | €99,034 | -€27,469 | -21.7% |
| Income taxes | 67/77 | €36,726 | €21,044 | -€15,682 | -42.7% |
| Profit (loss) for the period | 9904 | €89,776 | €77,990 | -€11,786 | -13.1% |
| Profit (loss) for the period to be appropriated | 9905 | €89,776 | €77,990 | -€11,786 | -13.1% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.